🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA · Read original ↗
Fezolinetant treatment is associated with a risk of drug induced liver injury. New recommendations have been introduced to minimise this risk. Liver function should be monitored before and during treatment in all patients ta…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.